Heartflow, Inc.(HTFL)Stock Analysis

HTFL Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Heartflow, Inc. (HTFL), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores HTFL at 45.3/100 on a 32-signal composite quality model, placing it at rank #1,728 of 2,879 stocks — the bottom half of the AI-ranked universe. HTFL scores in the top quartile across institutional flow (94.7), revenue growth (92.7). Areas of concern include profitability (30.0) and balance sheet strength (30.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 19.7/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), Heartflow, Inc. reports quarterly revenue of $52.6M, net income of $-27.4M, free cash flow of $-32.0M. Top institutional holders of HTFL by reported 13-F value include WELLINGTON MANAGEMENT GROUP LLP, Bain Capital Life Sciences Investors,, FMR, based on the most recent SEC filings. HTFL trades on the Nasdaq exchange and files with the SEC under CIK 1464521. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate HTFL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Heartflow, Inc. directly from SEC EDGAR.